Selected Publications
- Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: The EMPATROPISM-FE trial. Christiane E. Angermann, Susanne Sehner, Louisa M.S. Gerhardt, Carlos G. Santos-Gallego, Juan Antonio Requena-Ibanez, Tanja Zeller, Christoph Maack, Javier Sanz, Stefan Frantz, Georg Ertl, Juan J. Badimon. European Heart Journal
- Rationale and Design of the SOTA-P-CARDIA Trial (ATRU-V): Sotagliflozin in HFpEF Patients Without Diabetes. Maeve Soto Pérez, Jorge Rodríguez-Capitán, Juan Antonio Requena-Ibáñez, Carlos G. Santos-Gallego, M. Urooj Zafar, Ginés Escolar, Donna Mancini, Sumeet Mitter, David Lam, Johanna P. Contreras, Icilma Fergus, Farah Atallah-Lajam, Vivian Abascal, Anu Lala, Pedro Moreno, Noah Moss, Stamatios Lerakis, Javier Sanz, Valentin Fuster, Juan José Badimon. Cardiovascular Drugs and Therapy
- Does One Size Fits All?. Vanessa Roldan, Juan Jose Badimon. Cardiovascular Drugs and Therapy